ACE and chronic kidney disease: KDIGO 2012 guidelines [7] for the general management of CKD for diabetic and non-diabetic CKD patients recommend to aim for lowering blood pressure, using angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACE-I).